The Medical Advisor

Ivermectin Resources I have seen tremendous demand for some sort of initial guidance “WHERE TO START” with High Dose Ivermectin for CANCER. Editor's Note: Dr Makis proposes four distinct cancer protocols for using Ivermectin in cancer treatment, specifically for patients who have developed turbo cancer or aggressive cancers. These protocols, referred to as the “Dr. Makis Ivermectin Cancer Protocols,” are categorized based on dosage and the severity of the cancer. Updated version I have an article and a video that go into depth: June 10, 2024 - "15 minutes with Dr.Makis" - Episode 018: High Dose Ivermectin and Cancer .  2025 - 2026 studies on ivermectin for cancer Clinical Hulscher et al -  Real-World Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients : Results from a Prospective Observational Cohort (2026) Yuan Yuan et al (Cedars-Sinai Medical Center) - A phase I/II study evaluating the safety and efficacy of ivermectin in combination with balstilimab in p...

Executive Summary Cancer incidence is increasing for certain age groups and cancer types, especially among younger adults , but the reasons are complex and multifactorial: Cancer statistics from major registries (SEER and global data) show that some cancers (e.g., colorectal, thyroid, breast) have increased in younger adults over recent decades. ( PubMed ) Chronic inflammation and immune dysregulation are recognized contributors to cancer development, but they do not act in isolation and are not proven to be the single cause of rising cancer incidence. ( MDPI ) Lifestyle factors such as obesity, poor diet, smoking, and sedentary behavior are established contributors to cancer risk.  Emerging research continues to explore links between immune markers and cancer prognosis, but there is no strong evidence that infections like COVID-19 or vaccines cause cancer. ( Springer Nature Link ) Cancer prevention strategies supported by evidence include vaccination against oncogenic viruses (e...